# FDA Inspection 1218674 - Stemline Therapeutics, Inc. - August 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/stemline-therapeutics-inc/0b01f23c-836c-4fb9-bb1a-6fc19b4c3c15
Source feed: FDA_Inspections

> FDA Inspection 1218674 for Stemline Therapeutics, Inc. on August 31, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218674
- Company Name: Stemline Therapeutics, Inc.
- Inspection Date: 2023-08-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1054574 - 2018-05-01](https://www.keypedia.com/records/fda_inspections/stemline-therapeutics-inc/37684694-7cc5-4ca5-b043-fb37bef796b6)

Company: https://www.keypedia.com/companies/stemline-therapeutics-inc/21250514-bb46-4729-9657-03252dd4a4ac

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c